Why doctors do heart tests before or during Cosentyx (secukinumab) treatment?
Cosentyx (secukinumab) is an IL‑17A inhibitor used for conditions like plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. For most patients, routine “heart testing” is not required solely because of Cosentyx. Instead, heart-related checks are usually done because the underlying inflammatory diseases linked to these conditions raise cardiovascular risk over time, and because clinicians want to confirm there is no other reason for symptoms (like chest pain or shortness of breath).
In practice, heart tests may come up when:
- You have known heart disease or major risk factors (for example, prior heart attack, stroke, diabetes, smoking history).
- You develop new or worsening symptoms that could be cardiac (chest pressure, fainting, fast or irregular heartbeat, leg swelling).
- Your clinician needs baseline information if you are starting or adjusting therapy in the context of broader cardiovascular care.
What kinds of “heart tests” are typically considered, and what are they looking for?
When heart testing is done around biologic therapy, it is usually aimed at evaluating symptoms or baseline cardiovascular status rather than monitoring for a specific “Cosentyx heart toxicity.”
Common tests in these scenarios include:
- Electrocardiogram (ECG/EKG): looks for rhythm problems or patterns of prior ischemia.
- Echocardiogram: checks heart pumping function and valve issues, especially if symptoms suggest heart failure.
- Blood pressure monitoring and cardiovascular risk screening: supports long-term management of risk.
- Blood tests sometimes used in cardiac evaluation (depending on symptoms and clinician judgment), such as markers for inflammation or other conditions that can mimic or worsen cardiac symptoms.
The decision depends on your history and symptoms, not a universal Cosentyx schedule.
Does Cosentyx require routine cardiac monitoring like some other biologics?
There is no standard, universal requirement for routine cardiac monitoring in all patients just because they are taking Cosentyx. Clinicians generally follow a risk-based approach:
- If you have heart disease, clinicians may be more likely to order baseline or symptom-triggered testing.
- If you do not have heart disease and you have no cardiac symptoms, testing is usually driven by general preventive care and standard clinical evaluation.
What heart symptoms should prompt testing while on Cosentyx?
If you are taking Cosentyx and develop symptoms that could indicate heart problems, clinicians typically evaluate quickly rather than waiting for a routine follow-up. Symptoms that often trigger evaluation include:
- Chest pain or pressure, especially with activity
- Shortness of breath that is new or worsening
- Fainting or near-fainting
- New swelling in the legs or sudden weight gain (possible fluid retention)
- Palpitations or a feeling of irregular or very fast heartbeat
How does improving inflammation relate to cardiovascular risk?
Conditions treated with Cosentyx (especially psoriatic arthritis and ankylosing spondylitis) involve chronic inflammation, which is linked to higher cardiovascular risk. Treating the inflammatory disease can improve overall risk factors indirectly by reducing inflammation burden. That said, “inflammation control” is not a substitute for evaluating actual cardiac symptoms or known heart disease.
Heart testing, when needed, typically supports safe management of existing cardiovascular risk rather than detecting a predictable Cosentyx-specific cardiac problem.
Does Cosentyx interact with heart medications or change test results?
Cosentyx is a targeted biologic and does not have a well-known, universal pattern of directly interfering with standard heart tests. Still, heart-related test decisions can be affected by:
- The medications you already take (for example, anticoagulants, blood pressure drugs, antiarrhythmics), which influence what findings are relevant and how symptoms should be interpreted.
- Your baseline heart condition and comorbidities.
What should you ask your clinician about “heart tests” for your situation?
Because there is no one-size-fits-all heart-test plan, the most useful discussion usually includes:
- Whether you have cardiovascular risk factors that justify baseline evaluation
- Which symptoms would warrant urgent testing
- Whether you should coordinate with cardiology as part of your treatment plan
If you tell me which Cosentyx condition you’re treating (psoriasis, psoriatic arthritis, or ankylosing spondylitis) and whether you have any heart history or symptoms, I can help map out which heart tests are most commonly used in that specific context.